Hiroyuki Tanaka

587 total citations
56 papers, 410 citations indexed

About

Hiroyuki Tanaka is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Hiroyuki Tanaka has authored 56 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Epidemiology. Recurrent topics in Hiroyuki Tanaka's work include Medical Imaging and Pathology Studies (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Drug-Induced Adverse Reactions (4 papers). Hiroyuki Tanaka is often cited by papers focused on Medical Imaging and Pathology Studies (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Drug-Induced Adverse Reactions (4 papers). Hiroyuki Tanaka collaborates with scholars based in Japan, South Korea and United Kingdom. Hiroyuki Tanaka's co-authors include Toshiaki Isogai, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Toshihiro Ishii, Hiromasa Horiguchi, Tetsuro Ueda, Hiroichi Nagai, Munekazu Iinuma and Baolin Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Chromatography A and IEEE Transactions on Biomedical Engineering.

In The Last Decade

Hiroyuki Tanaka

49 papers receiving 397 citations

Peers

Hiroyuki Tanaka

CCM

RNMI

SURGE

PRM

Ionuţ Donoiu Romania

Kevin Ka‐Ho Kam Hong Kong

S. Yokoyama Japan

José Manuel Garrido Spain

Koji Orihara Japan

So Yeon Choi South Korea

Alexandru Dan Costache Romania

Thanat Chaikijurajai United States

Kristina Selthofer-Relatić Croatia

Shohei Ouchi Japan

Ionuţ Donoiu Romania

Hiroyuki Tanaka

258 ×1.7

CCM

67 ×1.0

56 ×0.9

RNMI

73 ×1.4

SURGE

65 ×1.3

PRM

Citations per year, relative to Hiroyuki Tanaka Hiroyuki Tanaka (= 1×) peers Ionuţ Donoiu

Countries citing papers authored by Hiroyuki Tanaka

Since Specialization

Citations

This map shows the geographic impact of Hiroyuki Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Tanaka more than expected).

Fields of papers citing papers by Hiroyuki Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Tanaka. The network helps show where Hiroyuki Tanaka may publish in the future.

Co-authorship network of co-authors of Hiroyuki Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Tanaka. A scholar is included among the top collaborators of Hiroyuki Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Tanaka. Hiroyuki Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Hiroyuki, et al.. (2025). Characteristics and patterns of adverse event reports in the Japanese Adverse Drug Event Report database over two decades (2004–2023): Exploring findings on sexes and age groups. Drug Discoveries & Therapeutics. 19(1). 10–21.

Denham, James W., et al.. (2024). Outwash Measurement of Joby Pre-Production Prototype. 1–10. 2 indexed citations

Tanaka, Hiroyuki, et al.. (2023). Characteristics of adverse event reports among people living with human immunodeficiency virus (HIV) in Japan: Data mining of the Japanese Adverse Drug Event Report database. Drug Discoveries & Therapeutics. 17(3). 183–190. 2 indexed citations

Isogai, Toshiaki, et al.. (2023). Incidence, management, and prognostic impact of arrhythmias in patients with Takotsubo syndrome: a nationwide retrospective cohort study. European Heart Journal Acute Cardiovascular Care. 12(12). 834–846. 4 indexed citations

Tanaka, Hiroyuki, Junichi Suwa, Yohei Maeda, et al.. (2023). Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia. Medicina. 59(4). 758–758.

Matsumoto, Takahiro, et al.. (2023). Bleeding events associated with recombinant human soluble thrombomodulin, classified according to renal function, in sepsis-induced disseminated intravascular coagulation. International Journal of Clinical Pharmacology and Therapeutics. 61(7). 297–305. 1 indexed citations

Nishimura, Masaki, Hiroyuki Tanaka, Nobuhiro Asai, et al.. (2017). Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion. Internal Medicine. 56(14). 1791–1797. 4 indexed citations

Isogai, Toshiaki, Hiroki Matsui, Hiroyuki Tanaka, Kiyohide Fushimi, & Hideo Yasunaga. (2017). Seasonal variation in patient characteristics and in-hospital outcomes of Takotsubo syndrome: a nationwide retrospective cohort study in Japan. Heart and Vessels. 32(10). 1271–1276. 11 indexed citations

Isogai, Toshiaki, Hideo Yasunaga, Hiroki Matsui, et al.. (2015). Effect of Intravenous Immunoglobulin for Fulminant Myocarditis on In-Hospital Mortality: Propensity Score Analyses. Journal of Cardiac Failure. 21(5). 391–397. 19 indexed citations

10.

Tanaka, Hiroyuki, Yasuhide Uwabe, Masao Sakai, et al.. (2007). Effectiveness of CT for Clinical Stratification of Occupational Lung Edema. Industrial Health. 45(1). 78–84. 2 indexed citations

11.

Tanaka, Hiroyuki, et al.. (2006). Immunopharmacological studies on the effects of Juzentaihoto and Hochuekkito on experimental autoimmune encephalomyelitis in rats. 23(6). 196–202. 2 indexed citations

12.

Liu, Baolin, et al.. (2004). Resveratrol Inhibits the Release of Mediators from Bone Marrow-Derived Mouse Mast cellsin vitro. Planta Medica. 70(4). 305–309. 51 indexed citations

13.

Tanaka, Hiroyuki, et al.. (2003). Protective Effect of Benidipine Against Sodium Azide-Induced Cell Death in Cultured Neonatal Rat Cardiac Myocytes. SHILAP Revista de lepidopterología. 2 indexed citations

14.

Tanaka, Hiroyuki & Hiroichi Nagai. (2002). Pathophysiology of airway mucosa.. Folia Pharmacologica Japonica. 120(1). 13–19. 1 indexed citations

15.

Wang, Ting, et al.. (2000). Effect of selective IL-6 inhibitor Am-80 on experimental autoimmune encephalomyelitis in DA rats.. PubMed. 21(11). 967–76. 7 indexed citations

16.

Imai, Yoshiko, et al.. (1999). The effect of methanolic extract from Corydalis Tuber on cytokine production and allergic reactions in experimental animals. 16(2). 51–57. 2 indexed citations

17.

Tanaka, Hiroyuki, et al.. (1997). Development of a novel octadecyl-bonded silica column and evaluation of its reliability in chromatographic analysis. Journal of Chromatography A. 762(1-2). 89–96. 8 indexed citations

18.

Tanaka, Hiroyuki & Takashi Deguchi. (1995). The protective effect of benidipine hydrochloride against hypoxic myocardial injury of cultured mouse fetal heart cells.. Folia Pharmacologica Japonica. 105(3). 161–169. 4 indexed citations

19.

Yamaguchi, Hisao, Hiroyuki Tanaka, Shigeru Obara, et al.. (1993). Changes in cardiac rhythm in man during underwater submersion and swimming studied by ECG telemetry. European Journal of Applied Physiology. 66(1). 43–48. 14 indexed citations

20.

Moriwake, Tadashi, et al.. (1992). Assessment of bone mineral density of the metacarpal bone using computed X-ray densitometry(CXD) during childhood.. 163. 915–916.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact